Elixxer Stock Buy Hold or Sell Recommendation
| ELXR Stock | CAD 1.15 0.00 0.00% |
Assuming the 90 days trading horizon and your way above-average risk tolerance, our recommendation regarding Elixxer is 'Strong Hold'. A buy or sell recommendation is an automated directive regarding whether to purchase or sell Elixxer given historical horizon and risk tolerance. When we issue a 'buy' or 'sell' recommendation for Elixxer, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out Elixxer Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note, we conduct extensive research on individual companies such as Elixxer and provide practical buy, sell, or hold advice based on investors' constraints. Elixxer. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
Elixxer |
Execute Elixxer Buy or Sell Advice
The Elixxer recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Elixxer. Macroaxis does not own or have any residual interests in Elixxer or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Elixxer's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Not Rated
Elixxer Trading Alerts and Improvement Suggestions
| Elixxer generated a negative expected return over the last 90 days | |
| Elixxer may become a speculative penny stock | |
| Elixxer has a very high chance of going through financial distress in the upcoming years | |
| Elixxer has accumulated 4.41 M in total debt with debt to equity ratio (D/E) of 1.96, which is about average as compared to similar companies. Elixxer has a current ratio of 0.06, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Elixxer until it has trouble settling it off, either with new capital or with free cash flow. So, Elixxer's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Elixxer sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Elixxer to invest in growth at high rates of return. When we think about Elixxer's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the revenue of 82.13 K. Net Loss for the year was (6.17 M) with profit before overhead, payroll, taxes, and interest of 42.41 K. | |
| Elixxer has accumulated about 969.92 K in cash with (2.35 M) of positive cash flow from operations. | |
| Latest headline from news.google.com: Elixxer Announces Appointment of Fiona Fitzmaurice as Chief Financial Officer - Yahoo Finance |
Elixxer Cash Flow Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Investments | (3.7M) | 1.1M | 2.2M | 2.3M | 3.2M | 3.4M | |
| Change In Cash | (4.5M) | 1.2M | (1.8M) | (236.3K) | (79.7K) | (75.7K) | |
| Net Income | (18.9M) | (9.8M) | (3.7M) | (14.2M) | (6.2M) | (6.5M) | |
| End Period Cash Flow | 924.5K | 2.1M | 301.8K | 65.4K | 111.8K | 106.2K | |
| Net Borrowings | 4.1M | 2.7M | 161.6K | 1.0M | 938.7K | 1.7M | |
| Depreciation | 2.0K | 2.0K | 2.0K | 494.0 | 568.1 | 539.69 |
Elixxer Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Elixxer or Pharmaceuticals sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Elixxer's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Elixxer stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.00 | |
β | Beta against Dow Jones | 0.00 | |
σ | Overall volatility | 0.00 | |
Ir | Information ratio | 0.00 |
Elixxer Volatility Alert
At this time Elixxer exhibits very low volatility. Elixxer is a potential penny stock. Although Elixxer may be in fact a good instrument to invest, many penny stocks are speculative in nature and are subject to artificial price hype. Please make sure you totally understand the upside potential and downside risk of investing in Elixxer. We encourage investors to look for signals such as email spams, message board hypes, claims of breakthroughs, volume upswings, sudden news releases, promotions that are not reported, or demotions released before SEC filings. Please also check biographies and work history of current and past company officers before investing in high volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on Elixxer instrument if you perfectly time your entry and exit. However, remember that penny stocks that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.Elixxer Fundamentals Vs Peers
Comparing Elixxer's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Elixxer's direct or indirect competition across all of the common fundamentals between Elixxer and the related equities. This way, we can detect undervalued stocks with similar characteristics as Elixxer or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Elixxer's fundamental indicators could also be used in its relative valuation, which is a method of valuing Elixxer by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Elixxer to competition |
| Fundamentals | Elixxer | Peer Average |
| Return On Equity | -10.14 | -0.31 |
| Return On Asset | -0.3 | -0.14 |
| Current Valuation | 21.92 M | 16.62 B |
| Shares Outstanding | 11.34 M | 571.82 M |
| Shares Owned By Institutions | 32.04 % | 39.21 % |
| Number Of Shares Shorted | 238 | 4.71 M |
| Price To Book | 2.67 X | 9.51 X |
| Price To Sales | 767,774 X | 11.42 X |
| Revenue | 82.13 K | 9.43 B |
| Gross Profit | 42.41 K | 27.38 B |
| EBITDA | (2.5 M) | 3.9 B |
| Net Income | (6.17 M) | 570.98 M |
| Cash And Equivalents | 969.92 K | 2.7 B |
| Total Debt | 4.41 M | 5.32 B |
| Debt To Equity | 1.96 % | 48.70 % |
| Current Ratio | 0.06 X | 2.16 X |
| Book Value Per Share | (0.76) X | 1.93 K |
| Cash Flow From Operations | (2.35 M) | 971.22 M |
| Short Ratio | 0.67 X | 4.00 X |
| Earnings Per Share | (1.02) X | 3.12 X |
| Beta | 0.87 | -0.15 |
| Market Capitalization | 13.05 M | 19.03 B |
| Total Asset | 5.37 M | 29.47 B |
| Retained Earnings | (80.5 M) | 9.33 B |
| Working Capital | (4.81 M) | 1.48 B |
| Net Asset | 5.37 M |
Elixxer Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Elixxer . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Elixxer Buy or Sell Advice
When is the right time to buy or sell Elixxer? Buying financial instruments such as Elixxer Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Elixxer in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Cash Cows Thematic Idea Now
Cash Cows
Entities with stable and reliable earnings or profits, which allows them to pay consistent dividends to their shareholders. The Cash Cows theme has 25 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Cash Cows Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Elixxer Stock Analysis
When running Elixxer's price analysis, check to measure Elixxer's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Elixxer is operating at the current time. Most of Elixxer's value examination focuses on studying past and present price action to predict the probability of Elixxer's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Elixxer's price. Additionally, you may evaluate how the addition of Elixxer to your portfolios can decrease your overall portfolio volatility.